Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Tremblay

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
Hepatology (Baltimore, Md.)|September 14, 2017
Reassessing the safety concerns of utilizing blood donations from patients with hemochromatosisAdam C Winters, Douglas Tremblay, Suzanne Arinsburg, et al.
Digestive Diseases and Sciences|November 5, 2020
Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein ThrombosisLeonard Naymagon, Douglas Tremblay, Nicole Zubizarreta, et al.
European Journal of Haematology|July 29, 2023
An overlooked mimic? Autoimmune myelofibrosis-A scoping review of the literatureYosef Joseph Rene Amel Riazat-Kesh, Alexander Maraveyas, Lily Martin, et al.
American Journal of Clinical Pathology|May 5, 2022
The Quantification and Significance of Extramedullary Hematopoiesis Seen on Liver Biopsy SpecimensDouglas Tremblay, Shahram Saberi, John Mascarenhas, et al.
The Oncologist|April 1, 2021
Contemporary Risk Stratification and Treatment of Chronic Myelomonocytic LeukemiaDouglas Tremblay, Noa Rippel, Jonathan Feld, et al.
Leukemia|October 13, 2021
Combined Drug Targeting of p53-dependent and -independent Pathways Depletes Myelofibrosis Hematopoietic Stem/Progenitor CellsMin Lu, Lijuan Xia, Nada Elmansy, et al.
Journal of Thrombosis and Thrombolysis|February 9, 2020
Portal vein thrombosis patients harboring JAK2V617F have poor long-term outcomes despite anticoagulationLeonard Naymagon, Douglas Tremblay, Nicole Zubizarreta, et al.
Leukemia Research|February 9, 2024
Systematic review and meta-analysis evaluating clinical outcomes in adult acute myeloid leukemia patients with central nervous system involvementHannah Goulart, Dahniel Sastow, Erin Moshier, et al.
Leukemia Research|March 13, 2022
Myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis: Ringing in a new futureDaniel I Nathan, Jonathan Feld, Siraj M El Jamal, et al.
Acta Haematologica|September 26, 2023
Exclusion of Acute Myeloid Leukemia Patients with Central Nervous System Involvement from Clinical Trials: An Analysis of the National Institutes of Health Clinical Trials Registry from 2012 to 2022Dahniel Sastow, Grace Van Hyfte, Jonathan Feld, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Hepatology (Baltimore, Md.)|September 14, 2017
Reassessing the safety concerns of utilizing blood donations from patients with hemochromatosisAdam C Winters, Douglas Tremblay, Suzanne Arinsburg, et al.
Digestive Diseases and Sciences|November 5, 2020
Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein ThrombosisLeonard Naymagon, Douglas Tremblay, Nicole Zubizarreta, et al.
European Journal of Haematology|July 29, 2023
An overlooked mimic? Autoimmune myelofibrosis-A scoping review of the literatureYosef Joseph Rene Amel Riazat-Kesh, Alexander Maraveyas, Lily Martin, et al.
American Journal of Clinical Pathology|May 5, 2022
The Quantification and Significance of Extramedullary Hematopoiesis Seen on Liver Biopsy SpecimensDouglas Tremblay, Shahram Saberi, John Mascarenhas, et al.
The Oncologist|April 1, 2021
Contemporary Risk Stratification and Treatment of Chronic Myelomonocytic LeukemiaDouglas Tremblay, Noa Rippel, Jonathan Feld, et al.
Leukemia|October 13, 2021
Combined Drug Targeting of p53-dependent and -independent Pathways Depletes Myelofibrosis Hematopoietic Stem/Progenitor CellsMin Lu, Lijuan Xia, Nada Elmansy, et al.
Journal of Thrombosis and Thrombolysis|February 9, 2020
Portal vein thrombosis patients harboring JAK2V617F have poor long-term outcomes despite anticoagulationLeonard Naymagon, Douglas Tremblay, Nicole Zubizarreta, et al.
Leukemia Research|February 9, 2024
Systematic review and meta-analysis evaluating clinical outcomes in adult acute myeloid leukemia patients with central nervous system involvementHannah Goulart, Dahniel Sastow, Erin Moshier, et al.
Leukemia Research|March 13, 2022
Myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis: Ringing in a new futureDaniel I Nathan, Jonathan Feld, Siraj M El Jamal, et al.
Acta Haematologica|September 26, 2023
Exclusion of Acute Myeloid Leukemia Patients with Central Nervous System Involvement from Clinical Trials: An Analysis of the National Institutes of Health Clinical Trials Registry from 2012 to 2022Dahniel Sastow, Grace Van Hyfte, Jonathan Feld, et al.
Pageof 11